Japanese
English
Home
About Us
Message from CEO
Our Mission
Our Business
Corporate Information
Leadership/ Governance
Access
Our Science
PRIME Technology
Application of Our Technology
Pipelines
Our Partners
IR
IR News
Management
Top Message
Corporate Governance
Disclosure Policy
Financial Highlights
IR Library
Financial Results
Presentation Materials
Securities Report
IR Materials
For Shareholders
Stock Overview
General Meeting of Shareholders
Stock Quotations
IR Calendar
IR FAQ
IR Contact
Disclaimer
Careers
Contact Us
Contact Us
Create the Future to Overcome Cancer
Notice from Noile
Notice From Noile about Impersonation Message (PDF)
News
2026/08/06
A Patent for Technology under Development Granted in EU
2026/07/16
Noile-Immune Biotech's PRIME CAR-T cells were featured on TV Asahi’s “Shinichi Hatori Morning Show” on July 16.
2026/07/09
Joint Research Results on Swift PRIME CAR-T Cells Manufactured Using a Short-Term Culture Method Published in Molecular Cancer Therapeutics
2026/06/02
Joint Research Project on in vivo CAR-T Therapy Conducted by The University of Tokyo and Yamaguchi University, Collaborative Partners of Noile-Immune, Awarded AMED FY2026 “Project for Promotion of Cancer Research and Therapeutic Evolution”
2026/06/01
AMED FY2026 “Translational Research Project” Grant Awarded to a Joint Research and Development Project Conducted by Yamaguchi University and Kyushu University, Collaborative Partners of Noile-Immune
Details
